Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: Hepatocellular carcinoma (HCC) is the second greatest cause of cancer-related fatalities globally, with few possible treatments for studied cases with advanced HCC. As a result, there is a strong desire to develop novel alternatives therapies to cure HCC. Mesenchymal stem cells (MSCs) and MSC-derived conditioned medium (CM) has proven to be a fruitful strategy. The current research aimed to investigate role of human umblical cord MSCs (huc-MSC) & their derived CM in alleviation of HCC and clarifying related molecular mechanisms. Methods: Rats were formed into 4 groups: normal controls (group I), HCC group (II), HCC rats which received Mesenchymal stem cells from human umbilical cord blood (huc-MSCs group III), HCC treated with huc-MSCs-CM (CM group IV). Relative expression of hepatic miR 19a and the mRNA expression of PTEN were investigated using quantitative real-time PCR